RxDoctor Payments Data

Amanda Fuhrer

Physician Assistant · Carmel, INNPI 1528074333

Payments from drug & device makers

$1,951in general payments, 2019–2025

Across 85 payments — averaging $22.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$300
  • Pfizer$185
  • Rochester Medical Corporation$146
  • Johnson & Johnson$120
  • Axonics, Inc.$114
  • Urogen Pharma, Inc.$110
  • plus $978 from 22 others

What the payments were for

  • Food & beverage$1,951100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,951 in reported general payments places this provider in the 80th percentile of 1,955 physician assistant providers in Indiana.

See all physician assistant providers in Indiana

Medicare billing

Part B allowed, 2024
$156,013
Medicare patients
170
Services billed
1,718

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron42$35,568
MyrbetriqMirabegron36$24,125
Tamsulosin Hcl58$759
Cephalexin35$216
NitrofurantoinNitrofurantoin Macrocrystal12$145
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$33

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$105$35,56842 claims
Astellas Pharma US IncMyrbetriq$85$24,12536 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,955 physician assistant providers in Indiana.

Other physician assistant in Carmel

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →